Importance of meta-analysis of long-term trials of low–molecular-weight heparin vs vitamin K antagonist in pulmonary embolism

[...]the idea is to look for a new potential subgroup (noncancer high-risk patients) in PTE/VTE long-term trials of LMWH vs VKA who may have significantly better response to LMWH (in comparison to VKA), as already demonstrated for cancer patients.

Saved in:
Bibliographic Details
Published in:The American journal of emergency medicine 2013-03, Vol.31 (3), p.627-628
Main Author: Koracevic, Goran P.
Format: Article
Language:English
Subjects:
Advantages
Anticoagulants
Anticoagulants - therapeutic use
Cancer
Drug therapy
Emergency
Emergency medical care
Heparin, Low-Molecular-Weight - therapeutic use
Humans
Meta-Analysis as Topic
Pulmonary Embolism - prevention & control
Secondary Prevention
Vitamin K - antagonists & inhibitors
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]the idea is to look for a new potential subgroup (noncancer high-risk patients) in PTE/VTE long-term trials of LMWH vs VKA who may have significantly better response to LMWH (in comparison to VKA), as already demonstrated for cancer patients.
ISSN:0735-6757
1532-8171
DOI:10.1016/j.ajem.2012.12.012